Tillkännagivande • Nov 01
HeiQ Plc, Annual General Meeting, Nov 25, 2024 HeiQ Plc, Annual General Meeting, Nov 25, 2024. Location: the offices of russell speechlys llp, 5 fleet place, ec4m 7rd, london United Kingdom Tillkännagivande • Oct 23
HeiQ Announces Restructuring and Delisting The Directors of HeiQ Plc have concluded that the administrative, regulatory and cost burden associated with maintaining the Company's listing is, in their opinion, disproportionate to the benefits. In order to implement the restructuring programme, as well as to assist in the Company's financing efforts for its ventures, the Board has therefore concluded that it is necessary to cancel the listing of the Company's ordinary shares (the "Shares") on the Official List (equity shares (transition) category) of the Financial Conduct Authority ("FCA") and to cancel the admission to trading of the Shares on the Main Market for listed securities of the London Stock Exchange ("LSE") (the "Delisting"). The Directors believe that the Delisting would facilitate its restructuring programme, through a major reduction in annualized costs associated with being a listed company. Furthermore, the Directors believe that the Delisting would greatly assist the Company to raise financing in the private markets for its venture platforms at higher valuations and enable their growth and value creation for Company's shareholders. As a company listed on the equity shares (transition) category, the Company is not required to obtain the approval of shareholders for the Delisting but is required under UK Listing Rule 21.2.17 to give at least 20 business days' notice of the intended cancellation. Accordingly, HeiQ has requested that (i) the FCA cancel the listing of the Shares on the Official List of the FCA, and that (ii) the LSE cancels the admission to trading of the Shares on the Main Market for listed securities of the LSE. It is anticipated that the Delisting will become effective from 08:00 a.m. (London time) on 19 November 2024. Investors holding Shares following the Delisting will remain a shareholder of HeiQ plc and continue to be entitled to exercise all of the rights attaching to the Shares and their attention is drawn to the paragraph below entitled "Dealing Arrangements". The Company intends to publish its Annual Accounts for the 18-month period ending 30 June 2024 by 31 October 2024, as required by the UK Listing Rules. The Company's 2024 Annual General Meeting is expected to take place in November 2024, further details of which will be announced in due course. New Risk • Oct 23
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €5.56m (US$6.01m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (27% average weekly change). Market cap is less than US$10m (€5.56m market cap, or US$6.01m). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Currently unprofitable and not forecast to become profitable over next 2 years (US$8.0m net loss in 2 years). Shareholders have been diluted in the past year (20% increase in shares outstanding). New Risk • Oct 14
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (23% average weekly change). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Currently unprofitable and not forecast to become profitable over next 2 years (US$8.0m net loss in 2 years). Shareholders have been diluted in the past year (20% increase in shares outstanding). Market cap is less than US$100m (€12.9m market cap, or US$14.1m). Recent Insider Transactions • Sep 17
Co-founder recently bought €59k worth of stock On the 13th of September, Carlo Centonze bought around 1m shares on-market at roughly €0.059 per share. This transaction amounted to 11% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Carlo's only on-market trade for the last 12 months. Tillkännagivande • Sep 12
HeiQ plc Provides Earnings Guidance for the First Half Year of 2024 and Eighteen Months Commencing 1 January 2023 to 30 June 2024 HeiQ Plc provided earnings guidance for the first half year of 2024 and eighteen months commencing 1 January 2023 to 30 June 2024. Despite these challenges, the Company has managed to maintain relatively stable revenue generation over the past 24 months and expects to report total revenues of approximately USD 62 million for the 18-month period (FY 2022 12-month period: USD 47 million). Therefore, losses from operations for the period are expected to be approximately USD 18 million, significantly reduced from USD 29 million in Fiscal Year 2022 (12-months).
For the first half year of 2024, the company expects revenues of USD 20.4 million. The loss from operations for the six months to 30 June 2024 is expected to be USD 6 million (USD 3.5 million excluding depreciation & amortization charges). New Risk • Jul 23
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$8.0m net loss in 2 years). Shareholders have been diluted in the past year (20% increase in shares outstanding). Market cap is less than US$100m (€18.4m market cap, or US$20.0m). Tillkännagivande • May 15
Ecolab and HeiQ Introduces Synbiotic Cleaning Products at Interclean Ecolab and HeiQ Chrisal have teamed up to launch the revolutionary Maxx Synbiotic cleaning range at Interclean in Amsterdam, The Netherlands. Ecolab, a global sustainability leader offering water, hygiene, and infection prevention solutions and services, and HeiQ Chrisal, a leading biotech innovator, are proudly collaborating to introduce advanced synbiotic cleaning products to the European cleaning industry. At Interclean in Amsterdam, May 14-17, the Maxx Synbiotic range will be introduced to the professional cleaning industry throughout Europe. Harnessing the power of pre- and probiotics, the 50 billion probiotics per liter of Maxx Synbiotic deliver immediate, continuous, and microscopic-level cleaning, highly efficient odor reduction, long-lasting efficacy, and support for a well-balanced microbiome on surfaces. HeiQ's synbiotic cleaning technology was validated in several scientific studies, e.g. the landmark study published in May 2023 in The Lancet by renowned Charité University Hospital Berlin. Reported Earnings • Mar 29
Full year 2023 earnings released: US$0.097 loss per share (vs US$0.22 loss in FY 2022) Full year 2023 results: US$0.097 loss per share (improved from US$0.22 loss in FY 2022). Revenue: US$41.7m (down 12% from FY 2022). Net loss: US$13.6m (loss narrowed 54% from FY 2022). Revenue is forecast to grow 5.4% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 26 percentage points per year, which is a significant difference in performance. Tillkännagivande • Mar 13
HeiQ Plc Announces Board Changes, with Effect from 1 April 2024 HeiQ Plc announced the appointment of Robert Van de Kerkhof as Chairman of the Company, with effect from 1 April 2024. Robert was appointed Non-Executive Director of HeiQ in January 2024 and subsequently, Chair of HeiQ AeoniQ. He brings a wealth of invaluable experience, having spent over 30 years in general management and sustainability leadership positions across the textiles industry. The HeiQ announced that Esther Dale Kolb, current Chair, who is stepping down to pursue other interests. Esther joined HeiQ in July 2020 and retires after working more than 30 years in leadership and management positions in both the chemicals and textiles industries. Esther will remain with the business to ensure an orderly handover of duties to Robert. Tillkännagivande • Feb 23
HeiQ Plc has completed a Follow-on Equity Offering in the amount of £0.759404 million. HeiQ Plc has completed a Follow-on Equity Offering in the amount of £0.759404 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 862,069
Price\Range: £0.087
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 7,866,709
Price\Range: £0.087
Transaction Features: Subsequent Direct Listing New Risk • Feb 20
New minor risk - Financial position The company has less than a year of cash runway based on its current free cash flow. Free cash flow: -US$11m This is considered a minor risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (17% average weekly change). Minor Risks Less than 1 year of cash runway based on current free cash flow (-US$11m). Currently unprofitable and not forecast to become profitable over next 2 years (US$4.5m net loss in 2 years). Shareholders have been diluted in the past year (9.9% increase in shares outstanding). Market cap is less than US$100m (€16.7m market cap, or US$18.0m). Tillkännagivande • Feb 17
HeiQ Plc has filed a Follow-on Equity Offering in the amount of £0.075 million. HeiQ Plc has filed a Follow-on Equity Offering in the amount of £0.075 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 862,069
Price\Range: £0.087 Tillkännagivande • Nov 30
HeiQ Plc Appoints Robert van de Kerkhof as Non-Executive Director, Effective January 1, 2024 HeiQ Plc announced the appointment of Robert van de Kerkhof as Non-Executive Director, with effect from 1 January 2024, to the board of HeiQ plc and as Chairman of the Environmental, Occupation, Health & Safety and Sustainability Committee. Robert will also be appointed to the board of HeiQ AeoniQ Holding AG (in Switzerland), a subsidiary of HeiQ plc. Robert has over 30 years of experience in general management and sustainability leadership and extensive knowledge of the textiles industry, including cellulosic fiber technology. He is the founder of PEPPER-i2, an advisory company specializing in sustainability and circularity. Robert also serves as the Chief Sustainability Officer and as a Board Member, a position he has held since 2014, of Lenzing AG (ATX listed LNZ.VI). Robert will be leaving Lenzing and its Board on 31 December 2023. Robert joins HEIQ AeoniQ with the firm belief that the novel HEIQ AeoniQ man-made cellulosic fibers (MMCF) are one of the most promising solutions to decarbonizing the textile industry and achieving a path to net zero for brands. Robert has also held senior positions as President of the Austrian Fiber Institute, President and Board Member of CIRFS - the European Man-made Fibres Association, and Chairman of the ReHubs Business Council for Euratex, which is the voice of the European Apparel and Textile Industry. These roles further demonstrate his strong leadership experience and expertise within the textiles industry. Tillkännagivande • Nov 22
HeiQ Unveils HeiQ Skin Care - A Probiotics-Infused Textiles Technology HeiQ introduces a 100% biobased and long-lasting cosmetic finishing technology for textiles to the market. The new addition to the HeiQ portfolio harnesses the power of active probiotics and selected prebiotics to enhance the skin microbiome, turning the human's large organ into the best-looking one. HeiQ announced the launch of HeiQ Skin Care technology for next-to-skin apparel and home textiles. This revolutionary proprietary technology, 100% biobased and meticulously designed, marks a significant advancement in textile innovation. HeiQ Skin Care is a synbiotic textile finish aimed at providing a balanced microbiome for glowing skin, evenafter repeated use and washing of textiles. Unlike conventional products, HeiQ Skin Care utilizes slow-release prebiotics and probiotics seamlessly integrated into a biobased textile matrix, enriching the skin's microbiomediversity, and offering long-lasting cosmetic benefits. The synergistic combination of prebiotics and probiotics, known as synbiotics, delivers a soothing cosmetic skin treatment while one relax, work, or sleep. Probiotics not only restore and improve the skin's natural balance but also enhance its self-repair capabilities. Synbiotics promote skin renewal, rebalancing, and improved appearance, reducing the signs of aging and establishing a favorable environment for the skin's natural repair mechanisms. HeiQ Skin Care is suitable for all textile fibers, both natural and synthetic, and can be applied to all textile items that come in direct contact with the skin. This versatility makes it an ideal choice for daily use- at work, during sports, leisure activities, or as bedding items like bed sheets and pillows. Intensive wear trials conducted during the development stage have proven the consistent release of synbiotics (prebiotics and probiotics) onto the skin, creating conditions to foster a well-balanced microbiome. New Risk • Nov 05
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 4.4% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Shares are highly illiquid. Minor Risks Large one-off items impacting financial results. Shareholders have been diluted in the past year (4.4% increase in shares outstanding). Market cap is less than US$100m (€33.1m market cap, or US$35.5m). Reported Earnings • Nov 05
First half 2022 earnings released: EPS: US$0.008 (vs US$0.025 in 1H 2021) First half 2022 results: EPS: US$0.008 (down from US$0.025 in 1H 2021). Revenue: US$30.3m (up 17% from 1H 2021). Net income: US$1.11m (down 64% from 1H 2021). Profit margin: 3.7% (down from 12% in 1H 2021). Board Change • Nov 03
Less than half of directors are independent There are 4 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 new directors. 7 experienced directors. 1 highly experienced director. 2 independent directors (3 non-independent directors). Independent Non-Executive Director Ben Bergo is the most experienced director on the board, commencing their role in 2014. Independent Non-Executive Director Karen Brade was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors. Tillkännagivande • Jun 30
HeiQ Plc, Annual General Meeting, Jun 29, 2023 HeiQ Plc, Annual General Meeting, Jun 29, 2023. Agenda: To Reappoint DELOITTE as the company's auditor; to authorise the approval of the auditor's remuneration; to renew the directors' authority to allot shares; to renew the director's authority to disapply pre-emption rights; to authorise the company to purchase its own shares; to reduce the notice period for general meetings; and to authorise the company to send information to shareholders by electronic means. Board Change • Apr 11
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 5 new directors. 6 experienced directors. 1 highly experienced director. 2 independent directors (3 non-independent directors). Independent Non-Executive Director Ben Bergo is the most experienced director on the board, commencing their role in 2014. Independent Non-Executive Director Karen Brade was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Tillkännagivande • Jan 13
HeiQ Plc (LSE:HEIQ) acquired Tarn-Pure Holdings Ltd for £0.85 million. HeiQ Plc (LSE:HEIQ) signed an agreement to acquire Tarn-Pure Holdings Ltd for £0.85 million on January 4, 2023. Under the terms of agreement HeiQ will pay a consideration of approximately £0.85million, subject to adjustments for cash, working capital and debt positions as of closing date. The consideration is agreed to be paid 50% in cash and 50% through the issue of new ordinary shares in HeiQ Plc to the vendorsat a significant premium to the closing market price as of January 3, 2023. The Company accordingly expects to issue approximately 613,000 new ordinary shares and the exact number of shares to be issued will be announced upon closing of the transaction. The transaction is expected to close later in January.
HeiQ Plc (LSE:HEIQ) completed the acquisition of Tarn-Pure Holdings Ltd on January 12, 2023. As on January 12, 2023, the deal structure got changed. HeiQ Plc will pay £0.53 million cash and issue 455,435 new ordinary shares of 30p each with issue price of 69.6p per share which represents a significant premium to the current share price as a part of total consideration £0.85 million. Recent Insider Transactions • Jan 08
Co-founder recently bought €95k worth of stock On the 4th of January, Carlo Centonze bought around 300k shares on-market at roughly €0.32 per share. This transaction amounted to 2.2% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Carlo has been a buyer over the last 12 months, purchasing a net total of €213k worth in shares. Tillkännagivande • Jan 05
HeiQ Plc (LSE:HEIQ) signed an agreement to acquire Tarn-Pure Holdings Ltd for £850,000. HeiQ Plc (LSE:HEIQ) signed an agreement to acquire Tarn-Pure Holdings Ltd for £850,000 on January 4, 2023. Under the terms of agreement HeiQ will pay a consideration of approximately £850,000, subject to adjustments for cash, working capital and debt positions as of closing date. The consideration is agreed to be paid 50% in cash and 50% through the issue of new ordinary shares in HeiQ Plc to the vendorsat a significant premium to the closing market price as of January 3, 2023. The Company accordingly expects to issue approximately 613,000 new ordinary shares and the exact number of shares to be issued will be announced upon closing of the transaction. The transaction is expected to close later in January. Tillkännagivande • Dec 15
HeiQ Plc acquired additional 20% stake in Chrisal NV from four minority shareholders for €2.7 million. HeiQ Plc acquired additional 20% stake in Chrisal NV from four minority shareholders for €2.7 million on December 14, 2022. HeiQ will issue 3.348164 million new ordinary shares in the Company. The purchase follows the decision by four minority shareholders to exercise their option on December 02, 2022 to sell their shares to HeiQ.HeiQ Plc completed the acquisition of additional 20% stake in Chrisal NV from four minority shareholders on December 14, 2022. Board Change • Nov 17
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 5 new directors. 6 experienced directors. 1 highly experienced director. 2 independent directors (3 non-independent directors). Independent Non-Executive Director Ben Bergo is the most experienced director on the board, commencing their role in 2014. Independent Non-Executive Director Karen Brade was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Tillkännagivande • Nov 16
The LYCRA Company and HeiQ Introduce New LYCRA® naturalFX™ Technology That Offers Durable Comfort Stretch and Fit for 100% Cotton Knitwear The LYCRA Company, announced the launch of LYCRA® naturalFX™ technology, a proprietary textile finishing process for 100% cotton knit garments designed for mass market applications. Developed in collaboration with HeiQ, an industry leader in performance finish technologies, this application is the latest example of both companies’ ongoing efforts to bring more innovative and sustainable textile technologies to consumers worldwide. LYCRA® naturalFX™ technology, powered by HeiQ, enhances cotton knitwear, addressing critical consumer pain points, and improving the consumer’s overall wearing experience. This technology provides durable comfort stretch, fit, and soft hand-feel to 100% cotton knitwear compared to conventional finishes. Even after repeated washing and wearing, LYCRA® naturalFX™ technology helps knitwear retain its shape, which helps extend the garment’s lifespan and potentially reduce its environmental impact. While The LYCRA Company is leading the commercialization of this technology, HeiQ will collaborate and support the introduction through their brand network as well as manufacturing and selling the finishing directly to textile mills, leveraging their established global technical services to deliver optimized performance. Reported Earnings • Sep 14
First half 2022 earnings released: EPS: US$0 (vs US$0.025 in 1H 2021) First half 2022 results: EPS: US$0 (down from US$0.025 in 1H 2021). Revenue: US$30.3m (up 17% from 1H 2021). Net income: US$1.11m (down 64% from 1H 2021). Profit margin: 3.7% (down from 12% in 1H 2021). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 1.0% growth forecast for the Chemicals industry in Germany. Valuation Update With 7 Day Price Move • Jun 17
Investor sentiment deteriorated over the past week After last week's 16% share price decline to €1.07, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 10x in the Chemicals industry in Germany. Total loss to shareholders of 50% over the past year. Tillkännagivande • May 19
HeiQ Plc, Annual General Meeting, Jun 29, 2022 HeiQ Plc, Annual General Meeting, Jun 29, 2022, at 09:00 Coordinated Universal Time. Location: at the offices of Charles Russell Speechlys LLP, 5 Fleet Place London United Kingdom Reported Earnings • Apr 29
Full year 2021 earnings released: EPS: US$0.021 (vs US$0.044 in FY 2020) Full year 2021 results: EPS: US$0.021 (down from US$0.044 in FY 2020). Revenue: US$57.9m (up 15% from FY 2020). Net income: US$2.68m (down 46% from FY 2020). Profit margin: 4.6% (down from 9.9% in FY 2020). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 6.0%, compared to a 10% growth forecast for the industry in Germany. Board Change • Apr 27
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 5 new directors. 7 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Independent Non-Executive Director Ben Bergo is the most experienced director on the board, commencing their role in 2014. Independent Non-Executive Director Karen Brade was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Tillkännagivande • Feb 15
HeiQ Plc announced that it has received $5 million in funding from Hugo Boss AG HeiQ Plc announced that it has raised $5 million in an equity round of funding from new investor Hugo Boss AG on February 14, 2022. Tillkännagivande • Jan 14
HeiQ Plc Launches World's First Dual Action Textile Cooling Technology HeiQ Plc announced the launch of a new dual action textile cooling technology, HeiQ Cool, the world's first textile technology to deliver both instant contact cooling and continuous evaporative cooling. Addressing the importance of body temperature control, whereby both overheating and feeling chilly are problematic, HeiQ Cool powered fabrics constantly regulate the skin temperature with a dual cooling capability. In a first step, melting energy absorption delivers instant contact cooling before the first sign of sweat and delays the build-up of heat, followed by a vaporizing energy action that mimics the skin's thermal regulating system by providing continuous evaporative cooling as long as the body is hot and sweaty. Suitable for all fabrics, the initial launch focuses on home textiles, especially sleeping products such as mattress ticking, pillows and bed linen because of its clear benefit to help users get a good night's sleep. It cools before the first sign of sweat, delays the build-up of heat and continuously regulates the temperature. Instantly cool to the touch, the components synergistically recharge the surface layer ensuring a consistently cool, dry and comfortable body climate. The biobased vegetable oil-derived thermo-functional polymer absorbs heat energy, giving an instant cooling sensation. If the body continues to heat up, perspiration is generated and the patented hydro-functional polymer transports moisture away together with the heat, creating a continuous cooling effect that stops once cooling is complete. The combination of a hydro-functional polymer with biobased vegetable oil-derived thermo-functional polymer formulation of HeiQ Cool contains more than 50% USDA® certified biobased content. It is also OEKO-TEX class 1 suited and meets most brand RSL (restricted substances list) requirements. Reported Earnings • Sep 29
First half 2021 earnings released: EPS US$0.025 (vs US$0.083 in 1H 2020) The company reported a poor first half result with weaker earnings, revenues and profit margins. First half 2021 results: Revenue: US$25.8m (down 14% from 1H 2020). Net income: US$3.13m (down 64% from 1H 2020). Profit margin: 12% (down from 29% in 1H 2020). Tillkännagivande • Sep 23
Heiq plc and the Lycra Company Launch Lycra Freshfx Brand with Heiq Technology for the China Market HeiQ Plc and The LYCRA Company announced they will be introducing LYCRA freshFX brand with HeiQ technology for the China market. Garments made with LYCRA freshFX brand with HeiQ technology will offer consumers the renowned LYCRA fiber benefits of lasting comfort, fit and shape, combined with HeiQ’s freshness and hygiene textile technologies. From odor absorption, antimicrobial to antiviral, with bio-based, mineral-based and silver-based technologies, HeiQ provides a comprehensive product range, now available with fabrics made with LYCRA fiber. Valuation Update With 7 Day Price Move • Jul 02
Investor sentiment deteriorated over the past week After last week's 18% share price decline to US$1.70, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 17x in the Chemicals industry in Germany. Simply Wall St's valuation model estimates the intrinsic value at €1.40 per share. Tillkännagivande • Jun 15
HeiQ Plc (LSE:HEIQ) agreed to acquire Life Material Technologies Limited for $9.2 million. HeiQ Plc (LSE:HEIQ) agreed to acquire Life Material Technologies Limited for $9.2 million on June 15, 2021. Under the terms, HeiQ Plc will pay $2.55 million in cash and $3.9 million in new ordinary shares. Additional earn-out consideration of up to $2.8 million may be payable equally in cash and through the issue of new ordinary shares subject of financial performance during 2021. Life Material Technologies reported revenue of $3.6 million and realised net income of $0.4 million during the year ended December 31, 2020. Tom E. S. Ellefsen shall become a member of the HeiQ executive management team and will continue to lead the business. Closing of the transaction is expected on June 30, 2021. Charles Cannon Brookes of Arlington Group Asset Management Limited, Financial Advisory Arm acted as financial advisor to HeiQ Plc. Tillkännagivande • May 06
HeiQ Launches High-Tech Mask Featuring Ground-Breaking Copper Technology Shown to Deactivate the COVID-19 Virus in Five Minutes HeiQ, launched HeiQ MetalliQ, a futuristic-looking, high-tech surgical mask that destroys all viruses and bacteria tested, up to 100% efficacy. HeiQ MetalliQ doesn't only look metallic. The mask with a patented design actually contains an ultra-thin pure copper coating applied via a high-tech vapor deposition process, called HeiQ MetalliX, which converts a minute amount of copper into vapour, allowing it to be deposited evenly to surround each fibre. HeiQ MetalliX is a patent-pending technology, created by HeiQ's innovation partner, Australian materials technology company, Xefco. Studies conducted by the Peter Doherty Institute for Infection and Immunity in Melbourne, Australia (Doherty Institute) showed that fabrics treated by the HeiQ MetalliX technology significantly deactivated the infectious SARS-CoV-2 virus in as little as 5 minutes. The testing protocol simulated the real-life interaction of aerosol droplets contaminating textile products such as face masks. Each sample was exposed to a high loading of SARS-CoV-2 followed by 5, 15 and 30 minutes incubation at room temperature before the amount of remaining infectious SARS-CoV-2 viruses was measured. The fabric samples treated with HeiQ MetalliX indicated a virus reduction of over 97.79% in five minutes, 99.95% in 15 minutes and over 99.99% in 30 minutes, relative to the inoculum control. Copper is a naturally occurring element, present in the earth's crust, soil, oceans, lakes and rivers. It is also a trace element that occurs naturally in all humans, plants and animals. The antiviral, antibacterial and antifungal properties of copper have been known for centuries and have been demonstrated by many laboratory studies. HeiQ MetalliX treated materials release copper ions which deactivate viruses and bacteria. Treated materials have also been tested to kill 100% of Staphylococcus aureus and Klebsiella pneumoniae and deactivate 99.95% of H1N1 virus and 99.9% of Human Coronavirus 229E. Made in EU, HeiQ MetalliQ is manufactured in HeiQ Medica in Spain where HeiQ also conducts R&D activities for medical devices. Throughout the development of the HeiQ MetalliX technology, Xefco worked closely with long-standing research partner the Institute for Frontier Materials (IFM) at Deakin University, as part of the world-class ARC Research Hub for Future Fibres, of which HeiQ is also a member. Tillkännagivande • Apr 30
HeiQ Plc (LSE:HEIQ) acquired RAS AG for €10.2 million. HeiQ Plc (LSE:HEIQ) acquired RAS AG for €10.2 million on April 29, 2021. Under he terms of the transaction, consideration is payable as €1.25 million in cash and €3.85 million through the issue of 1,701,821 new ordinary shares by HeiQ. It includes an additional earn out consideration dependent on RAS AG's growth and 2021 calendar year EBIT. The earn out consideration is capped at an additional €5 million in shares for achieving a €2 million EBIT in 2021 and will be satisfied through the issuance of new ordinary shares. For the year ended December 31, 2020, RAS AG reported a revenue of €2.5 million and an EBITDA of €0.52 million. Charles Cannon Brookes of Arlington Group Asset Management Limited acted as financial advisor to HeiQ Plc .
HeiQ Plc (LSE:HEIQ) completed the acquisition of RAS AG on April 29, 2021. Tillkännagivande • Mar 12
HeiQ Viroblock Partnership with Berger Paint HeiQ announce that it has signed an agreement with global luxury paint provider Berger Paints India Ltd. ("Berger"), among the 15 paint companies in the world. Berger will produce an innovative antiviral paint, Silk Breathe Easy, which will be powered by HeiQ Viroblock, proven to destroy over 99.99% of infectious viruses and bacteria. Tillkännagivande • Mar 05
HeiQ Plc (LSE:HEIQ) signed an agreement to acquire 51% stake in Chrisal N.V for €7.5 million. HeiQ Plc (LSE:HEIQ) signed an agreement to acquire 51% stake in Chrisal N.V for €7.5 million on March 3, 2021. Under the terms of consideration, €5.0 million payable in cash and €2.5 million through the issue of 1,101,928 new ordinary shares by HeiQ. On completion, Chrisal will be renamed HeiQ Chrisal. For year ended December 31, 2020, Chrisal recorded revenue of €5.5 million and an operating profit of €1.6 million. The Acquisition includes a bottling facility in Belgium. This is an important infrastructure requirement for HeiQ's ambitions in functional textile aftercare and other fields. The current Chrisal President and Founder Corrie Gielen and its Chief executive officer Robin Temmerman will continue to lead the business, supported by the existing Chrisal team. HeiQ co-Founder and Group Chief Carlo Centonze as well as Group Chief financial officer Xaver Hangartner will join the HeiQ Chrisal Board of Directors and will explore further synergies over the course of 2021. Charles Cannon Brookes of Arlington Group Asset Management Limited acted as financial advisor to HeiQ Plc . Tillkännagivande • Feb 11
HeiQ Plc Signs Four Year Partnership with Girbau HeiQ Plc announced that it has signed a four year partnership with Girbau. The contract is valued at a minimum of $1.5 million, with the potential to increase substantially. Pursuant to this contract, Girbau will offer its customers HeiQ's Viroblock NPJ03 product as an antiviral and antimicrobial post-treatment for its industrial laundry services. HeiQ and Girbau also plan to offer solutions to public launderettes, bringing branded HeiQ Viroblock dispensers to consumers. While the HeiQ Viroblock technology platform consists of multiple different applications and is active in various sectors, this is the first time that HeiQ Viroblock has been utilised within the laundry sector. This means that HeiQ Viroblock has the potential to become a household detergent product as a post-treatment for laundered goods, opening up a large and growing new market to HeiQ. The laundry detergent market is estimated at $132 billion per year and grows at 4.5% CAGR. Tillkännagivande • Jan 29
HeiQ Plc Announces Launch of HeiQ Viroblock Permanent HeiQ announce the launch of HeiQ Viroblock Permanent, a new innovation under the HeiQ Viroblock technology platform. HeiQ Viroblock Permanent is being used exclusively on Meryl® Skinlife Force, a new sustainable, antimicrobial and durable premium fabric.
Meryl® Skinlife Force has been developed in partnership with Nylstar SL, a pioneer in hydrogen technology in high-tech yarn production, and a long term customer of HeiQ. HeiQ supplies a blend of manufactured raw materials for the fabrication of Meryl® Skinlife Force powered by HeiQ Viroblock Permanent, and will share a percentage of the net sales of this fabric. This agreement is in line with the Company's strategy to grow its high margin royalty and licensing business and increase its share of the $10 billion antimicrobial fabric industry. Part of the royalty earned will be reinvested to promote the HeiQ Viroblock technology platform to drive its ongoing success and brand equity. Tillkännagivande • Dec 17
HeiQ Plc (LSE:HEIQ) acquired an unknown majority stake in MasFabEs S.L. HeiQ Plc (LSE:HEIQ) acquired an unknown majority stake in MasFabEs S.L. on December 15, 2020. MasFabEs S.L. has been renamed HeiQ Medica S.L. Charles Cannon Brookes of Arlington Group Asset Management Limited acted as financial advisor to HeiQ.
HeiQ Plc (LSE:HEIQ) completed the acquisition of an unknown majority stake in MasFabEs S.L. on December 15, 2020.